12:00 AM
 | 
Feb 07, 2011
 |  BC Week In Review  |  Company News  |  Deals

MDxHealth, Pfizer, Cancer Research Technology, University of Newcastle deal

MDxHealth partnered with Pfizer, Cancer Research Technology (CRT) and the university to identify and develop a biomarker to predict a patient's response to Pfizer's cancer candidate PF-01367338. The poly(ADP-ribose)...

Read the full 143 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >